Advertisement
UK markets closed

  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     

  • HANG SENG

    16,828.93
    +317.24 (+1.92%)
     

  • CRUDE OIL

    83.36
    +1.46 (+1.78%)
     

  • GOLD FUTURES

    2,336.50
    -9.90 (-0.42%)
     

  • DOW

    38,508.62
    +268.64 (+0.70%)
     

  • Bitcoin GBP

    53,396.46
    +56.01 (+0.11%)
     

  • CMC Crypto 200

    1,431.81
    +17.05 (+1.21%)
     

  • NASDAQ Composite

    15,701.44
    +250.13 (+1.62%)
     

  • UK FTSE All Share

    4,378.75
    +16.15 (+0.37%)
     
Money:

What is the true cost of the UK state pension?

To get a sense of the true value of the state pension, you can look at how much you would need to save to match it yourself

Global Keloid Treatment Market (2021 to 2026) - by Product, Treatment and Geography

Research and Markets
·6-min read

Dublin, June 18, 2021 (GLOBE NEWSWIRE) -- The "Keloid Treatment Market (2021 - 2026)" report has been added to ResearchAndMarkets.com's offering.

Keloid scars are heap-up scars which are developed with injuries causing due to, acne, burns, ear piercing, chickenpox, surgical cuts, scratches and vaccination sites and build up abruptly on the skin surface. Keloid scars develop commonly in people between age group 10 to 20 years of age. Globally, development of advance technology based treatment, rise in the appearance consciousness, and increasing awareness about scare treatment products, and expenditure on personal care, and changing lifestyle are the prime growth drivers of global keloid treatment market. In addition, increase in adoption of of radiation therapy, surgical intervention, and steroid injections and, emerging economies such as China, India and others, will create new opportunities for global keloid treatment market. However, higher cost of treatment, and risk of side effects and complications during treatment are the key restraints for global keloid treatment market.

This report identifies the global keloid treatment market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to global keloid treatment market.

Geographically North America dominated global keloid treatment market, and Asia Pacific is projected to have fastest growth, owing to rapidly increasing aging population, growing disposable income, rising focus on personal well-being and modernizing healthcare infrastructure in this region. Among all the treatments, surgical treatment segment has the highest market share in global keloid treatment market.

This report segments global keloid treatment market on the basis of product, treatment, and regional market as follows:

  • Keloid Treatment Market, By Product: Elastic Wraps, Sprays, Ointment, Creams, Oils, and Topical Gels & Gel Sheets

  • The report has focused study on keloid treatment market by basis of treatment such as: Radiation Therapy, Cry Therapy, Surgical Treatment, Laser Treatment, Steroid Injections, and Interferon

  • This is report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the keloid treatment market. Some of the major companies' profiles in detail are as follows:

  • Bristol-Myers Squibb Company

  • Valeant Pharmaceuticals International Inc.

  • Renovo Group Plc

  • Galena Biopharma, Inc.

  • Pacific World Corporation

ADVERTISEMENT

Key Topics Covered:

1. Keloid Treatment Market - Overview

2. Keloid Treatment Market - Executive summary

3. Keloid Treatment Market
3.1. Comparative analysis
3.1.1. Product Benchmarking - Top 10 companies
3.1.2. Top 5 Financials Analysis
3.1.3. Market Value split by Top 10 companies
3.1.4. Patent Analysis - Top 10 companies
3.1.5. Pricing Analysis

4. Keloid Treatment Market Forces
4.1. Drivers
4.2. Constraints
4.3. Challenges
4.4. Porters five force model

5. Keloid Treatment Market - Strategic analysis
5.1. Value chain analysis
5.2. Opportunities analysis
5.3. Product life cycle
5.4. Suppliers and distributors Market Share

6. Keloid Treatment Market - By Product (Market Size -$Million / $Billion)
6.1. Market Size and Market Share Analysis
6.2. Application Revenue and Trend Research
6.3. Product Segment Analysis
6.3.1. Elastic Wraps
6.3.2. Sprays
6.3.3. Ointment
6.3.4. Creams
6.3.5. Oils
6.3.6. Topical Gels & Gel Sheets

7. Keloid Treatment Market - By Treatment (Market Size -$Million / $Billion)
7.1. Radiation Therapy
7.2. Cry Therapy
7.3. Surgical Treatment
7.4. Laser Treatment
7.5. Steroid Injections
7.6. Interferon

8. Keloid Treatment - By Geography (Market Size -$Million / $Billion)
8.1. Keloid Treatment Market - North America Segment Research
8.2. North America Market Research (Million / $Billion)
8.2.1. Segment type Size and Market Size Analysis
8.2.2. Revenue and Trends
8.2.3. Application Revenue and Trends by type of Application
8.2.4. Company Revenue and Product Analysis
8.2.5. North America Product type and Application Market Size
8.2.5.1. U.S.
8.2.5.2. Canada
8.2.5.3. Mexico
8.2.5.4. Rest of North America
8.3. Keloid Treatment - South America Segment Research
8.4. South America Market Research (Market Size -$Million / $Billion)
8.4.1. Segment type Size and Market Size Analysis
8.4.2. Revenue and Trends
8.4.3. Application Revenue and Trends by type of Application
8.4.4. Company Revenue and Product Analysis
8.4.5. South America Product type and Application Market Size
8.4.5.1. Brazil
8.4.5.2. Venezuela
8.4.5.3. Argentina
8.4.5.4. Ecuador
8.4.5.5. Peru
8.4.5.6. Colombia
8.4.5.7. Costa Rica
8.4.5.8. Rest of South America
8.5. Keloid Treatment - Europe Segment Research
8.6. Europe Market Research (Market Size -$Million / $Billion)
8.6.1. Segment type Size and Market Size Analysis
8.6.2. Revenue and Trends
8.6.3. Application Revenue and Trends by type of Application
8.6.4. Company Revenue and Product Analysis
8.6.5. Europe Segment Product type and Application Market Size
8.6.5.1. U.K
8.6.5.2. Germany
8.6.5.3. Italy
8.6.5.4. France
8.6.5.5. Netherlands
8.6.5.6. Belgium
8.6.5.7. Spain
8.6.5.8. Denmark
8.6.5.9. Rest of Europe
8.7. Keloid Treatment - APAC Segment Research
8.8. APAC Market Research (Market Size -$Million / $Billion)
8.8.1. Segment type Size and Market Size Analysis
8.8.2. Revenue and Trends
8.8.3. Application Revenue and Trends by type of Application
8.8.4. Company Revenue and Product Analysis
8.8.5. APAC Segment - Product type and Application Market Size
8.8.5.1. China
8.8.5.2. Australia
8.8.5.3. Japan
8.8.5.4. South Korea
8.8.5.5. India
8.8.5.6. Taiwan
8.8.5.7. Malaysia

9. Keloid Treatment Market - Entropy
9.1. New product launches
9.2. M&A's, collaborations, JVs and partnerships

10. Keloid Treatment Market Company Analysis
10.1. Market Share, Company Revenue, Products, M&A, Developments
10.2. Bristol-Myers Squibb Company
10.3. Valeant Pharmaceuticals International Inc.
10.4. Renovo Group Plc
10.5. Galena Biopharma, Inc.
10.6. Pacific World Corporation
10.7. RXi Pharmaceuticals, Inc.
10.8. Novartis AG
10.9. GlaxoSmithKline plc
10.10. Revitol Corporation Inc.
10.11. Avita Medical Limited

11. Keloid Treatment Market - Appendix

12. Keloid Treatment Market - Methodology

For more information about this report visit https://www.researchandmarkets.com/r/8qmrpv

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900